This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saito, T. Articles by Mori, M. Search for Related Content PubMed PubMed Citation Articles by Saito, T. Articles by Mori, M.

Differential Activation of Epidermal Growth Factor (EGF) Receptor Downstream Signaling Pathways by Betacellulin and EGF

Department of Medicine and Molecular Science (T.S., S.O., E.Y., M.S., Y.U., H.S., M.M.), Gunma University Graduate School of Medicine, Gunma 371-8511, Japan; Gunma University Health and Medical Center (K.O.), Gunma 371-8510, Japan; and Department of Pharmacological Sciences (J.E.P.), State University of New York-Stony Brook, Stony Brook, New York 11794

Address all correspondence and requests for reprints to: Shuichi Okada, Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan. E-mail: okadash{at}showa.gunma-u.ac.jp.

To determine the downstream signaling pathways regulated by betacellulin (BTC) in comparison with epidermal growth factor (EGF), we used Chinese hamster ovary cells overexpressing the human EGF receptor (ErbB1/EGFR). The overall time-dependent activation of EGFR autophosphorylation was identical in cells treated with 1 nM BTC or 1.5 nM EGF. Analysis of site-specific EGFR phosphorylation demonstrated that the BTC and EGF tyrosine phosphorylation of Y1086 was not significantly different. In contrast, the autophosphorylation of Y1173 was markedly reduced in BTC-stimulated cells, compared with EGF stimulation that directly correlated with a reduced BTC stimulation of Shc tyrosine phosphorylation, Ras, and Raf-1 activation. On the other hand, Y1068 phosphorylation was significantly increased after BTC stimulation, compared with EGF in parallel with a greater extent of Erk phosphorylation. Expression of a dominant interfering MEK kinase 1 (MEKK1) and Y1068F EGFR more efficiently blocked the enhanced Erk activation by BTC, compared with EGF. Interestingly BTC had a greater inhibitory effect on apoptosis, compared with EGF, and expression of Y1068F EGFR abolished this enhanced inhibitory effect. Together, these data indicated that although BTC and EGF share overlapping signaling properties, the ability of BTC to enhance Erk activation occurs independent of Ras. The increased BTC activation results from a greater extent of Y1068 EGFR tyrosine phosphorylation and subsequent increased recruitment of the Grb2-MEKK1 complex to the plasma membrane, compared with EGF stimulation. The increased Erk activation by BTC associated with antiapoptotic function.

This article has been cited by other articles:

				S. Panigone, M. Hsieh, M. Fu, L. Persani, and M. Conti Luteinizing Hormone Signaling in Preovulatory Follicles Involves Early Activation of the Epidermal Growth Factor Receptor Pathway Mol. Endocrinol., April 1, 2008; 22(4): 924 - 936. [Abstract] [Full Text] [PDF]

				A. A Gratao, M. Dahlhoff, F. Sinowatz, E. Wolf, and M. R Schneider Betacellulin Overexpression in the Mouse Ovary Leads to MAPK3/MAPK1 Hyperactivation and Reduces Litter Size by Impairing Fertilization Biol Reprod, January 1, 2008; 78(1): 43 - 52. [Abstract] [Full Text] [PDF]

				H. M. El-Shewy, M.-H. Lee, L. M. Obeid, A. A. Jaffa, and L. M. Luttrell The Insulin-like Growth Factor Type 1 and Insulin-like Growth Factor Type 2/Mannose-6-phosphate Receptors Independently Regulate ERK1/2 Activity in HEK293 Cells J. Biol. Chem., September 7, 2007; 282(36): 26150 - 26157. [Abstract] [Full Text] [PDF]

				C. T. Charalambous, A. Hannigan, P. Tsimbouri, G. M. McPhee, and J. B. Wilson Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF{alpha} prior to neoplasia Carcinogenesis, August 1, 2007; 28(8): 1839 - 1848. [Abstract] [Full Text] [PDF]

				H. Oster and M. Leitges Protein Kinase C {alpha} but not PKC{zeta} Suppresses Intestinal Tumor Formation in ApcMin/+ Mice. Cancer Res., July 15, 2006; 66(14): 6955 - 6963. [Abstract] [Full Text] [PDF]

				Y. Nakano, H. Furuta, A. Doi, S. Matsuno, T. Nakagawa, H. Shimomura, S. Sakagashira, Y. Horikawa, M. Nishi, H. Sasaki, et al. A Functional Variant in the Human Betacellulin Gene Promoter Is Associated With Type 2 Diabetes Diabetes, December 1, 2005; 54(12): 3560 - 3566. [Abstract] [Full Text] [PDF]

				S. Bouyain, P. A. Longo, S. Li, K. M. Ferguson, and D. J. Leahy The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand PNAS, October 18, 2005; 102(42): 15024 - 15029. [Abstract] [Full Text] [PDF]

				Y. Sun and F. A. Sinicrope Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells Mol. Cancer Ther., January 1, 2005; 4(1): 51 - 59. [Abstract] [Full Text] [PDF]